Inventor · disambiguated record
Ravi Upasani
Also filed as: UPASANI RAVI
10 granted patents·1 pending application·78 citations·filing 2000–2024
88Inventor score
Technology areasA61P
Top patents by PatentIndex Score
11 records- 0194US11702421B2Substituted pyridines as irreversible inhibitors of menin-MLL interactionBIOMEA FUSION LLC·Filed 2021·Granted Jul 18, 2023·6 cites·4 claims
- 0293US11084825B2Substituted pyridines as irreversible inhibitors of menin-MLL interactionBIOMEA FUSION LLC·Filed 2019·Granted Aug 10, 2021·19 cites·26 claims
- 0390US11174263B2Inhibitors of menin-MLL interactionBIOMEA FUSION LLC·Filed 2019·Granted Nov 16, 2021·11 cites·25 claims
- 0487US6465472B1Substituted quinazolines and analogs and use thereofEURO CELTIQUE SA·Filed 2000·Granted Oct 15, 2002·26 cites·16 claims
- 0583US12116371B2Substituted pyridines as irreversible inhibitors of menin-MLL interactionBIOMEA FUSION INC·Filed 2023·Granted Oct 15, 2024·0 cites·14 claims
- 0682US2024376112A1N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINE CARBOXAMIDE AND USES THEREOFBIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 0780US12077544B2Irreversible inhibitors of menin-MLL interactionBIOMEA FUSION INC·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 0877US7652006B2Substituted 1(2H)-phthalazinones and pharmaceutical compositions thereofEURO CELTIQUE SA·Filed 2004·Granted Jan 26, 2010·8 cites·9 claims
- 0977US6765006B2Substituted quinazolines and analogs and the use thereofEURO CELTIQUE SA·Filed 2002·Granted Jul 20, 2004·8 cites·11 claims
- 1076US12275739B2Inhibitors of menin-MLL interactionBIOMEA FUSION INC·Filed 2023·Granted Apr 15, 2025·0 cites·21 claims
- 1168US11845753B2Inhibitors of menin-mll interactionBIOMEA FUSION INC·Filed 2021·Granted Dec 19, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Ravi Upasani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →